You have 9 free searches left this month | for more free features.

CLADRIBINE

Showing 26 - 50 of 140

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia, Monocytic, Acute, Pediatric AML Trial in China (Cladribine, G-CSF, Cytarabine)

Recruiting
  • Leukemia, Monocytic, Acute
  • Pediatric AML
  • Cladribine
  • +5 more
  • Foshan, Guangdong, China
  • +8 more
Mar 28, 2022

Lymphoma Trial in Houston (2CdA, Cyclophosphamide, Rituximab)

Completed
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 3, 2022

Acute Myeloid Leukemia Trial in Seattle (drug, biological, other)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Cladribine
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 6, 2021

Acute Leukemia, in Relapse, Acute Leukemia Refractory Trial in Suzhou (CVA regimen bridging to HSCT)

Recruiting
  • Acute Leukemia, in Relapse
  • Acute Leukemia Refractory
  • CVA regimen bridging to HSCT
  • Suzhou, Jiangsu, China
    The First Affliated Hospital of Soochow University
Jan 4, 2022

Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia Trial in Seattle (Cladribine, Cytarabine,

Recruiting
  • Acute Biphenotypic Leukemia
  • +11 more
  • Cladribine
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Apr 22, 2022

Acute Myeloid Leukemia Trial in Lanzhou (Venetoclax, Azacitidine, Cladribine)

Recruiting
  • Acute Myeloid Leukemia
  • Lanzhou, Gansu, China
    Long Zhao
Apr 24, 2022

Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia, Myeloid Tumor Trial in Seattle (drug, biological, other)

Completed
  • Acute Leukemia of Ambiguous Lineage
  • +2 more
  • Cladribine
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Feb 23, 2022

High Risk Acute Myeloid Leukemia, Allogeneic Hematopoeitic Stem Cell Transplantation Trial in Shanghai (Cladribine, Fludarabine,

Recruiting
  • High Risk Acute Myeloid Leukemia
  • Allogeneic Hematopoeitic Stem Cell Transplantation
  • Cladribine
  • +3 more
  • Shanghai, Shanghai, China
    Shanghai general hospital, Shanghai Jiaotong university school o
Oct 10, 2021

High Risk Acute Myeloid Leukemia, Allogeneic Hematopoeitic Stem Cell Transplantation Trial in Shanghai (Cladribine, Fludarabine,

Recruiting
  • High Risk Acute Myeloid Leukemia
  • Allogeneic Hematopoeitic Stem Cell Transplantation
  • Cladribine
  • +3 more
  • Shanghai, Shanghai, China
    Shanghai general hospital, Shanghai Jiaotong university school o
Oct 10, 2021

Relationship Between Oral DMT Burden and Adherence in MS

Enrolling by invitation
  • Multiple Sclerosis
  • Adherence, Medication
  • Cladribine
  • +3 more
  • Melbourne, Victoria, Australia
    Monash University
Dec 16, 2020

Adult Acute Lymphocytic Leukemia Trial in Frankfurt (Cyclophosphamide, Dexamethasone, Vincristine)

Completed
  • Adult Acute Lymphocytic Leukemia
  • Frankfurt, Germany
    University of Frankfurt, Medical Dept. II
Aug 17, 2022

Acute Myeloid Leukemia Trial in Poland, United States (A arm (DA-90), B arm (DAC), A arm (CLAG-M))

Recruiting
  • Acute Myeloid Leukemia
  • A arm (DA-90)
  • +3 more
  • New York, New York
  • +9 more
Sep 30, 2021

Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell Trial in China (Chidamide, Cladribine, Gemcitabine)

Recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • Lymphoma, T-Cell
  • Deyang, Deyang, China
  • +10 more
Jul 21, 2022

Lymphoma, Mantle Cell Lymphoma, Indolent Lymphoma Trial in Tucson (rituximab, bortezomib, cladribine)

Completed
  • Lymphoma
  • +3 more
  • Tucson, Arizona
    The University of Arizona Cancer Center
Dec 16, 2019

Multiple Sclerosis Trial in Worldwide (Cladribine, Placebo, Interferon-beta (IFN-beta))

Completed
  • Multiple Sclerosis
  • Cladribine
  • +2 more
  • Cullman, Alabama
  • +38 more
Oct 8, 2020

Registry of Multiple Sclerosis Participated in Cladribine

Completed
  • Multiple Sclerosis
    • Cambridge, Massachusetts
      Outcome Sciences, Inc
    Oct 24, 2019

    Acute Myeloid Leukemia, Relapse Leukemia Trial in Guangzhou (Cladribine, G-CSF, Aclarubicin)

    Unknown status
    • Acute Myeloid Leukemia
    • Relapse Leukemia
    • Cladribine
    • +3 more
    • Guangzhou, Guangdong, China
      Liang Wang
    Aug 18, 2019

    Acute Lymphoblastic Leukemia Trial in GuangZhou (Cladribine, G-CSF, Cytarabine)

    Unknown status
    • Acute Lymphoblastic Leukemia
    • Cladribine
    • +3 more
    • GuangZhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Aug 18, 2019

    Relapsing-Remitting Multiple Sclerosis Trial in Worldwide (Cladribine, Placebo)

    Completed
    • Relapsing-Remitting Multiple Sclerosis
    • Cladribine
    • Placebo
    • Boulder, Colorado
    • +116 more
    Nov 10, 2020

    Hairy Cell Leukemia, Recurrent Hairy Cell Leukemia Trial in Houston (drug, other, biological)

    Recruiting
    • Hairy Cell Leukemia
    • Recurrent Hairy Cell Leukemia
    • Cladribine
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 20, 2020

    Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blasts 10 Percent or More of Bone Marrow

    Recruiting
    • Acute Myeloid Leukemia
    • +6 more
    • Cladribine
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 31, 2022

    Acute Myeloid Leukemia Trial in Hangzhou (D-CLAG)

    Recruiting
    • Acute Myeloid Leukemia
    • D-CLAG
    • Hangzhou, Zhejiang, China
      the First Affiliated Hospital,School of Medicine, Zhejiang Unive
    Sep 12, 2020

    Acute Myeloid Leukemia Trial in Suzhou (IAC regimen, High-dose IA regimen, Intermediate-dose IA regimen)

    Recruiting
    • Acute Myeloid Leukemia
    • IAC regimen
    • +2 more
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Feb 3, 2020

    Mixed Phenotype Acute Leukemia, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia Trial in

    Completed
    • Mixed Phenotype Acute Leukemia
    • +6 more
    • Cladribine
    • +5 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Feb 21, 2020

    Acute Myeloid Leukemia Trial in Saint Louis (Selinexor, Cladribine, G-CSF)

    Completed
    • Acute Myeloid Leukemia
    • Saint Louis, Missouri
      Washington University School of Medicine
    Mar 6, 2020